[1]
|
Sharma, R.P. and Chopra, V.L. (1976) Effect of the wingless (wgl) Mutation on Wing and Haltere Development in Drosophila melanogaster. Developmental Biology, 48, 461-465. https://doi.org/10.1016/0012-1606(76)90108-1
|
[2]
|
Roel, N. (2001) An Ancient Cluster of Wnt Paroloques. Trend in Genetics, 17, 443. https://doi.org/10.1016/S0168-9525(01)02349-6
|
[3]
|
张宁芳, 高鹏飞, 成志敏. Wnt信号通路对细胞增殖的调控[J]. 生命科学, 2018, 30(5): 551-558.
|
[4]
|
王奎淞, 张秋菊, 魏书瑶, 等. 舒肝和络醒脾方对肝纤维化模型大鼠肝组织Wnt/β-catenin信号通路的影响[J]. 临床肝胆病杂志, 2022, 38(10): 2265-2272.
|
[5]
|
田宇佳, 魏铭, 赵辉. Wnt/β-catenin信号通路在肿瘤干细胞中的作用研究进展[J]. 解放军医学杂志, 2022, 47(8): 831-837.
|
[6]
|
冯志强, 郭玉明, 等. 行肝切除术肝细胞癌患者炎性指标水平变化及与预后的相关性[J]. 中华实用诊断与治疗杂志, 2020, 34(9): 891-895.
|
[7]
|
周丹, 于洋, 安洋, 等. 表没食子儿茶素没食子酸酯通过Wnt/β-catenin信号通路改善免疫性肝炎小鼠肝损伤[J]. 解剖学研究, 2020, 42(1): 38-43.
|
[8]
|
殷辉, 毛重山, 曾艳丽, 李威, 康谊. Wnt3a在Toll样受体3介导的肝脏炎症中作用[J]. 中华实用诊断与治疗杂志, 2022, 36(6): 596-600.
|
[9]
|
樊爽. 人乙肝肝硬化组织中Wnt1的表达对肝卵圆细胞介导肝脏再生的影响[D]: [硕士学位论文]. 呼和浩特: 内蒙古医科大学, 2021.
|
[10]
|
Zhang, F., Wang, F. and He, J. (2021) Regulation of Hepatic Stellate Cell Contraction and Cirrhotic Portal Hypertension by Wnt/β-catenin Signalling via Interaction with Gli1. British Journal of Pharmacology, 178, 2246-2265. https://doi.org/10.1111/bph.15289
|
[11]
|
Katoh, M. (2018) Multi-Layered Prevention and Treatment of Chronic Inflammation, Organ Fibrosis and Cancer Associated with Canonical WNT/β-catenin Signaling Activation (Review). International Journal of Molecular Medicine, 42, 713-725. https://doi.org/10.3892/ijmm.2018.3689
|
[12]
|
杨慧玲, 刘小静, 秦丽君, 等. 乙型肝炎病毒感染对Wnt/β-catenin信号通路的影响机制研究[J]. 中华医院感染学杂志, 2020, 30(7): 976-980.
|
[13]
|
冯建超, 周进学, 李庆军. Wnt/β-catenin通路相关蛋白在乙型肝炎肝纤维化进程中的临床意义[J]. 中西医结合肝病杂志, 2022, 32(9): 794-798.
|
[14]
|
王丽惠. TGF-β1诱导大鼠肝星状细胞-T6细胞系活化及上皮间质转化的研究[D]: [硕士学位论文]. 厦门: 厦门大学, 2019.
|
[15]
|
Działo, E., Czepiel, M. and Tkacz, K. (2021) Wnt/β-catenin Signaling Promotes TGF-β-Mediated Activation of Human Cardiac Fibroblasts by Enhancing IL-11 Production. International Journal of Molecular Sciences, 22, Article 10072. https://doi.org/10.3390/ijms221810072
|
[16]
|
余亚平, 陈芝芸. 肝纤维化发生上皮——间叶质转化(EMT)的分子机制研究进展[J]. 医学理论与实践, 2019, 32(18): 2886-2888. https://doi.org/10.19381/j.issn.1001-7585.2019.18.010
|
[17]
|
Nusse, R. and Varmus, H.E. (1982) Many Tumors Induced by the Mouse Mammary Tumor Virus Contain a Provirus Integrated in the Same Region of the Host Genome. Cell, 31, 99-109. https://doi.org/10.1016/0092-8674(82)90409-3
|
[18]
|
叶善平. miR-557通过靶向RAB10调控Wnt/β-catenin信号通路抑制肝癌进展的机制研究[D]: [硕士学位论文]. 南昌: 南昌大学, 2021.
|
[19]
|
Fu, X., Zhu, X. and Qin, F. (2022) Linc00210 Drives Wnt/β-catenin Signaling Activation and Liver Tumor Progression through CTNNBIP1-Dependent Manner. Molecular Cancer, 21, Article No. 161. https://doi.org/10.1186/s12943-022-01633-6
|
[20]
|
杨茂, 邹清亮, 程丽. Wnt-β-catenin信号在肝脏发育再生和肝癌发生中的作用[J]. 成都医学院学报, 2020, 15(5): 669-672, 676.
|
[21]
|
冉玉. 儿童肝母细胞瘤临床特征、诊治疗效及预后危险因素分析[D]: [硕士学位论文]. 郑州: 郑州大学, 2021.
|
[22]
|
闵茜. β-catenin与Yes相关蛋白1在肝母细胞瘤发生中的作用研究[D]: [硕士学位论文]. 武汉: 武汉大学, 2019.
|
[23]
|
张财源, 李金凝, 刘欢欢. PRETEXT分期系统对儿童肝母细胞瘤病理学分型和疗效评估的价值分析[J]. 实用肝脏病杂志, 2018, 21(4): 505-508.
|
[24]
|
张文杰. LINC00665通过调控经典Wnt/β-catenin通路对肝母细胞瘤的增殖与凋亡的作用研究[D]: [硕士学位论文]. 沈阳: 中国医科大学, 2022.
|
[25]
|
程珍. miR-139-3p通过调控Wnt/β-catenin信号通路抑制肝母细胞瘤迁移、侵袭的研究[D]: [硕士学位论文]. 沈阳: 中国医科大学, 2022.
|
[26]
|
许飞, 张进, 马端. Hippo/YAP和Wnt/β-catenin通路的对话[J]. 遗传, 2014, 36(2): 95-102.
|
[27]
|
Yang, F., Fang, E. and Mei, H. (2019) Cis-Acting circ-CTNNB1 Promotes β-catenin Signaling and Cancer Progression via DDX3-Mediated Transactivation of YY1. Cancer Research, 79, 557-571. https://doi.org/10.1158/0008-5472.CAN-18-1559
|
[28]
|
Liang, B., Wang, H. and Qiao, Y. (2022) Differential Requirement of Hippo Cascade during CTNNB1 or AXIN1 Mutation-Driven Hepatocarcinogenesis. Hepatology, 77, 1929-1942. https://doi.org/10.1002/hep.32693
|
[29]
|
Li, J., Quan, H. and Liu, Q. (2013) Alterations of Axis Inhibition Protein 1 (AXIN1) in Hepatitis B Virus-Related Hepatocellular Carcinoma and Overexpression of AXIN1 Induces Apoptosis in Hepatocellular Cancer Cells. Oncology Research, 20, 281-288. https://doi.org/10.3727/096504013X13639794277608
|
[30]
|
Kakehashi, A., Stefanov, V.E. and Kawada, N. (2017) Proteome Characteristics of Non-Alcoholic Steatohepatitis Liver Tissue and Associated Hepatocellular Carcinomas. International Journal of Molecular Sciences, 18, Article 434. https://doi.org/10.3390/ijms18020434
|
[31]
|
Connor, F., Rayner, T.F., Santoyo-Lopez, J., et al. (2018) Mutational Landscape of a Chemically-Induced Mouse Model of Liver Cancer. Journal of Hepatology, 69, 840-850. https://doi.org/10.1016/j.jhep.2018.06.009
|
[32]
|
Gu, M.J. and Choi, J.H. (2012) Clinicopathological Significance of E-Cadherin, β-catenin and Epidermal Growth Factor Receptor Expression in Intrahepatic Cholangiocarcinoma. Hepatogastroenterology, 59, 1241-1244. https://doi.org/10.5754/hge11881
|
[33]
|
Song, F., Chen, F.Y. and Wu, S.Y. (2021) Mucin 1 Promotes Tumor Progression through Activating Wnt/β-catenin Signaling Pathway in Intrahepatic Cholangiocarcinoma. Journal of Cancer, 12, 6937-6947. https://doi.org/10.7150/jca.63235
|
[34]
|
Xue, W., Dong, B. and Zhao, Y. (2021) Upregulation of TTYH3 Promotes Epithelial-to-Mesenchymal Transition through Wnt/β-catenin Signaling and Inhibits Apoptosis in Cholangiocarcinoma. Cellular Oncology, 44, 1351-1361. https://doi.org/10.1007/s13402-021-00642-9
|
[35]
|
Deng, X., Jiang, P. and Chen, J. (2020) GATA6 Promotes Epithelial-Mesenchymal Transition and Metastasis through MUC1/β-catenin Pathway in Cholangiocarcinoma. Cell Death & Disease, 11, Article No. 860. https://doi.org/10.1038/s41419-020-03070-z
|
[36]
|
Merino-Azpitarte, M., Lozano, E. and Bujanda, L. (2017) SOX17 Regulates Cholangiocyte Differentiation and Acts as a Tumor Suppressor in Cholangiocarcinoma. Journal of Hepatology, 67, 72-83. https://doi.org/10.1016/j.jhep.2017.02.017
|
[37]
|
姜海涛, 张顺, 任燕萍. NS-398和DHA联合抑制β-catenin、c-myc对胆管癌QBC939细胞凋亡的影响[J]. 中华普通外科杂志, 2018, 33(5): 416-419.
|